e-learning
resources
Vienna 2009
Wednesday, 16.09.2009
Mechanisms of infection: what's new?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Enhance protection against nasopharyngeal carriage of
Streptococcus pneumoniae
elicited by live recombinant attenuated oral salmonella vaccines with PspA‘ and PsaA
Q. Ma, Q. Zhang, C. Wang (Chongqing, China; chongqing, Chile)
Source:
Annual Congress 2009 - Mechanisms of infection: what's new?
Session:
Mechanisms of infection: what's new?
Session type:
E-Communication Session
Number:
4779
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Q. Ma, Q. Zhang, C. Wang (Chongqing, China; chongqing, Chile). Enhance protection against nasopharyngeal carriage of
Streptococcus pneumoniae
elicited by live recombinant attenuated oral salmonella vaccines with PspA‘ and PsaA. Eur Respir J 2009; 34: Suppl. 53, 4779
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Impact of nasopharyngeal pneumococcal colonization on protective immunity against S. pneumoniae in mice
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
Pneumococcal vaccination: current and future issues
Source: Eur Respir J 2001; 18: 184-195
Year: 2001
Dynamics of serotypic composition of nasopharyngeal pneumococcal isolates in children pneumococcal nasopharyngeal colonization after the introduction of the vaccination program in Moscow
Source: Virtual Congress 2020 – Different aspects of paediatric viral and bacterial lung infections
Year: 2020
Practicalities of human inoculation to establish experimental pneumococcal carriage in vaccine studies
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010
Genetically modified
Salmonella typhimurium
(ST) for the intranasal vaccination against
Mycobacterium tuberculosis
(Mtb):
In vitro
and
in vivo
results from the sequella vaccine
Source: Eur Respir J 2002; 20: Suppl. 38, 11s
Year: 2002
Influenza and pneumococcal immunization initiates work
Source: Eur Respir J 2001; 18: Suppl. 33, 207s
Year: 2001
Safety and immunogenicity of hemophilus influenzae type B conjugate vaccine in COPD
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008
Efficacy of vaccination to prevent pneumococcal infection in organized communities
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Year: 2017
Late Breaking Abstract - Safety and immunogenicity of non-typeable H. influenzae (NTHi) and M. catarrhalis (Mcat) adjuvanted vaccines in adults
Source: International Congress 2018 – COPD exacerbations and bronchiectasis
Year: 2018
Immunogenicity and safety of a novel recombinant pandemic influenza vaccine containing a polysaccharide adjuvant
Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects
Year: 2010
Pneumococcal and influenza vaccination
Source: Respipedia Article
Year: 2018
Previous pneumococcal polysaccharide vaccine impacts immune response to subsequent pneumococcal conjugate vaccine in the elderly
Source: Eur Respir J 2005; 26: Suppl. 49, 673s
Year: 2005
Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly
Source: Eur Respir J 2010; 36: 608-614
Year: 2010
Vaccination of COPD patients with a pneumococcus type 6B tetanus toxoid conjugate vaccine
Source: Eur Respir J 2002; 20: 813-818
Year: 2002
Invasive pneumococcal disease (IPN) and pneumococcal vaccination in our setting
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
Protective efficacy and antigenicity of influenza HA-VLPs in a murine model of postinfluenza bacterial pneumonia.
Source: International Congress 2019 – Clinical challenges in respiratory infection
Year: 2019
Protective efficacy of virus like particles (VLPs) containing the influenza HA and/or NA in a murine model of postinfluenza bacterial pneumonia
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020
New arguments for double action release active drugs in preparation for vaccination against pneumococcus among children with chronic sites of infection in nasopharynx
Source: International Congress 2016 – Paediatric respiratory infections
Year: 2016
Additive preventive effect of influenza and pneumococcal vaccines in elderly persons
Source: Eur Respir J 2004; 23: 363-368
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept